Limes Schlosskliniken AG (XETRA:LIK.DE)
| Market Cap | 162.38M+50.3% |
| Revenue (ttm) | n/a+38.3% |
| Net Income | n/a+34.4% |
| EPS | n/a+33.2% |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1 |
| Open | 550.00 |
| Previous Close | 550.00 |
| Day's Range | 545.00 - 550.00 |
| 52-Week Range | 316.00 - 595.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About LIK.DE
LIMES Schlosskliniken AG operates private clinics for psychiatry, psychotherapy, and psychosomatics services in Germany, Switzerland, Italy, and Liechtenstein. The company focuses on the treatment of stress-related illnesses; and mental and psychological disorders, such as depression, acute burnout, affective disorders, trauma/PTSD, anxiety disorders, attention deficit hyperactivity disorder, personality disorder, chronic pain, psychoses, obsessive compulsive disorder, sleep disorder, somatoform disorder, and sports psychiatry. The company was formerly known as GMF Capital AG and changed its name to LIMES Schlosskliniken AG in December 2005. LIMES Schlosskliniken AG was founded in 2005 and is headquartered in Cologne, Germany. The company operates as a subsidiary of GMF Capital GmbH.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$LIK.DE stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in LIK.DE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by LIK.DE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
LIK.DE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New LIK.DE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to LIK.DE from public contracts
Source: USAspending.gov
LIK.DE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from LIK.DE’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score